The most significant shift in federal cannabis policy since 1970 directly impacts every licensed medical cannabis business in Mississippi.
On April 22, 2026, Acting Attorney General Todd Blanche signed a final order rescheduling medical marijuana from Schedule I to Schedule III under the Controlled Substances Act. The order took effect immediately and applies to all marijuana produced and distributed under qualifying state medical marijuana programs, including Mississippi’s medical cannabis program.
For Mississippi’s licensed dispensaries, cultivators, processors, and testing labs, this changes everything from taxes to federal compliance. Here’s what every Mississippi cannabis business owner needs to understand right now.
What the Rescheduling Order Actually Does
The Department of Justice order moves two categories of marijuana from Schedule I to Schedule III:
- FDA-approved drug products containing marijuana
- Marijuana subject to a qualifying state medical marijuana license
This means Mississippi’s medical cannabis program, licensed through the Mississippi State Department of Health, now falls under Schedule III of the Controlled Substances Act rather than Schedule I.
Adult-use or recreational marijuana remains federally prohibited as a Schedule I substance. Unlicensed cannabis operations and synthetically derived cannabinoids are also excluded from the rescheduling.
The June 22, 2026 DEA Registration Deadline
The most urgent action item for Mississippi cannabis businesses is the 60-day DEA registration window. All state-licensed medical marijuana operators must submit a DEA registration application by June 22, 2026.
Operators who submit a completed application by that deadline may continue operating under their Mississippi licenses while the DEA processes their applications, which is expected to take approximately six months.
The order does not provide clear guidance for operators who miss this deadline. Whether businesses that fail to apply within the 60-day window can continue operating solely under state law remains uncertain. Given this ambiguity, every licensed Mississippi cannabis business should prioritize submitting their DEA registration as soon as possible.
Registration Categories for Mississippi Businesses
The type of DEA registration required depends on your license type:
- Cultivators must register as bulk manufacturers – annual fee of $3,699
- Processors must register as manufacturers – annual fee of $3,699
- Dispensaries must register as distributors – annual fee of $1,850
Cultivators face an additional administrative fee of $113 per kilogram on harvested cannabis.
Major Tax Relief: Section 280E Is Gone for Medical Cannabis
One of the most significant financial impacts of the rescheduling is the elimination of Section 280E of the Internal Revenue Code for state-licensed medical marijuana operators.
Under the old Schedule I classification, cannabis businesses were taxed on gross income, meaning they could not deduct ordinary business expenses like rent, payroll, utilities, or marketing. This resulted in effective tax rates of 70% or higher for some cannabis businesses.
With the reclassification to Schedule III, Mississippi medical cannabis businesses can now deduct ordinary and necessary business expenses for federal tax purposes, just like any other legal business. This represents a massive financial shift that could mean the difference between profitability and closure for many operators.
Mississippi cannabis businesses should consult with their tax professionals immediately to understand how this change affects their 2026 tax filings and whether any retroactive relief may be available.
What This Means for Mississippi Patients
For patients holding Mississippi medical cannabis cards, the rescheduling validates what the state already recognized, that marijuana has accepted medical uses. While patients may not notice immediate changes in how they access their medicine, the long-term effects could be significant:
- More federally funded research into cannabis treatments could lead to better products and more targeted therapies
- Insurance coverage for medical cannabis becomes a more realistic possibility as marijuana gains “currently accepted medical use” status under federal law
- The stigma associated with using a Schedule I substance is reduced now that medical marijuana is classified alongside substances like ketamine and certain codeine products
New Federal Oversight and Compliance Requirements
The rescheduling is not without new obligations. Mississippi businesses that register with the DEA will be subject to federal compliance standards, inspections, and reporting requirements. However, the order is designed to work cooperatively with existing state regulatory systems.
Key provisions include:
- State medical marijuana licenses will be accepted as evidence of state-law authorization for DEA registration
- State-required records will be accepted in lieu of some federal reporting requirements
- State labeling, packaging, and security requirements may be used instead of certain federal requirements
This cooperative approach means Mississippi’s existing regulatory framework through the Department of Health should remain largely intact, with federal oversight layered on top rather than replacing state regulation.
What the Rescheduling Does NOT Do
It’s important to understand the limitations of this order:
- It does not legalize recreational marijuana at the federal level
- It does not resolve federal banking restrictions for cannabis businesses
- It does not allow interstate commerce of cannabis products
- It does not affect hemp, which remains outside the Controlled Substances Act
- Synthetic THC remains Schedule I
A broader administrative hearing is scheduled to begin June 29, 2026, to consider whether all marijuana, not just medical, should be reclassified to Schedule III. That hearing could further reshape the federal cannabis landscape.
What Mississippi Businesses Should Do Right Now
- Prepare your DEA registration application immediately. The June 22, 2026 deadline is firm and there is no clear guidance on what happens if you miss it.
- Consult with a cannabis attorney about the DEA registration process, compliance requirements, and how the new federal framework interacts with your Mississippi license.
- Talk to your tax professional about the elimination of Section 280E and how to restructure your tax strategy for 2026 and beyond.
- Review your operations for federal compliance readiness, including record-keeping, labeling, packaging, and security protocols.
- Monitor developments closely. The DEA hearing beginning June 29, 2026 will address broader rescheduling, and implementing regulations are still being finalized.
This article is for informational purposes only and does not constitute legal advice. Mississippi cannabis businesses should consult with qualified legal and tax professionals regarding the application of these federal changes to their specific operations.
MScannaBIZ is Mississippi’s premier cannabis business platform. For the latest news, deals, and industry updates, visit mscannabiz.com.
